-
4 days ago | 
appliedclinicaltrialsonline.com | Andy Studna
In a recent video interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer, Novotech discussed the company’s recent accomplishment of winning the Citeline CRO Partnership of the Year Award in recognition of its partnership with Tune Therapeutics.
-
5 days ago | 
appliedclinicaltrialsonline.com | Andy Studna
June 24, 2025By In this video interview, Judith Ng-Cashin, MD, chief medical officer, Novotech, emphasizes the importance of proactive communication, strategic alignment, and cross-functional collaboration in establishing strong, effective partnerships between CROs and pharmaceutical companies.
-
6 days ago | 
appliedclinicaltrialsonline.com | Andy Studna
June 23, 2025By In this video interview, Judith Ng-Cashin, MD, chief medical officer, Novotech, shares insights on how sponsors and CROs can cultivate a “one team” mindset by setting the right leadership tone, encouraging collaboration, and leveraging team-building strategies to drive clinical trial success.
-
1 week ago | 
appliedclinicaltrialsonline.com | Andy Studna
June 20, 2025By In this video interview, Judith Ng-Cashin, MD, chief medical officer, Novotech, shares why clear communication, strong leadership, and cultural alignment are essential to building effective partnerships between CROs, sponsors, and other stakeholders in clinical research.
-
1 week ago | 
appliedclinicaltrialsonline.com | Andy Studna
In a recent video interview with Applied Clinical Trials, Judith Ng-Cashin, MD, chief medical officer, Novotech discussed the company’s recent accomplishment of winning the Citeline CRO Partnership of the Year Award in recognition of its partnership with Tune Therapeutics.
-
1 week ago | 
appliedclinicaltrialsonline.com | Andy Studna
ACT: Could you elaborate on the importance of leadership in this current landscape of clinical research being impacted by regulatory and administrative shifts?
-
1 week ago | 
appliedclinicaltrialsonline.com | Andy Studna
In an interview with ACT senior editor Andy Studna at the 2025 DIA Global Annual Meeting, Carie Pierce, SVP, global head of growth & business development, DIA, shares her perspective on the progress of international regulatory initiatives like Project Orbis and highlights the industry’s renewed focus on scientific integrity amid global challenges. ACT: Looking back on the first half of the year, what are some achievements or advancements from the industry that have excited you most?
-
1 week ago | 
appliedclinicaltrialsonline.com | Andy Studna
Key takeawaysAI/ML adoption is growing in clinical trials, with reported benefits such as 18% time reduction and protocol optimization, though challenges remain around data quality, trust, and legal concerns. Companies are using AI/ML for protocol simplification, site burden analysis, and budget forecasting, helping to reduce complexity and improve trial efficiency.
-
1 week ago | 
appliedclinicaltrialsonline.com | Andy Studna
June 17, 2025By In this video interview, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer Network (NCCN), shares his perspective on how clinical operations teams can evolve through patient-centered trial design, multi-disciplinary support, and enhanced education to address persistent barriers in cancer trial enrollment over the next five years.
-
1 week ago | 
appliedclinicaltrialsonline.com | Andy Studna
ACT: What are some of the most exciting themes or trends in clinical research you’re looking to explore at this year’s Global Annual Meeting?
